Global Varicella Vaccine Market Trends & Future Opportunities Recorded until 2023

Published on : Jul 03, 2018

Albany, New York, July 3, 2018: Varicella vaccine or chickenpox vaccine, is widely used across the globe to offer protection against chickenpox. It should be noted that, a single dose of vaccine avoids 95% of moderate disease and 100% of severe disease. Market Research Hub (MRH) has recently included a new research study on varicella vaccine market with a prime focus on the worldwide market including prime regions such as North America, South America, Europe & Asia-Pacific and Middle East & Africa. This research assessment is titled “Global Varicella Vaccine Market by Manufacturers, Regions, Type and Application, Forecast to 2023”, which discourses vital facets such as market trends and opportunities expected to impact the concerned market in the near future.

As per key research findings, the growth rate experienced in developed regions such as the U.S. and Europe is not that quick since they have higher product coverage. Moreover, the count of neonatal in their countries is also decreasing. However, looking at the global market scenario, the worldwide market for varicella vaccine is likely grow at a 8.0% CAGR in the next five years. Going by this pace, the target market will soon reach a new revenue milestone of 4830 million US$ until 2023.

In the recent years, with significant recovery of global economic, the advancements across emerging countries as well as rising health concerns have been prominent. This trend will surely aid the consumption of varicella vaccine in the coming years; there is an optimistic upward shift which will motivate the vaccine market, especially in the developed nations. The later section of the report talks about the market segmentation in terms of manufacturers, type, regions and application. Based on type, the global market for varicella vaccine is divided into injection and freeze-dried powder. Furthermore, the major applications include kids’ injection and adults’ injection.

The analysis also stresses on the prime market players and their dominance in the global varicella vaccine market. Close to 72.50% of market share in production is acquired by the top five manufacturers. In addition, the top three players are GSK, Merck and Shanghai Institute; acquiring close to 52 percent in total. It is vital to knows that, United States giant Merck manages 30.40% market share (recorded in 2015), and is the leader across the varicella vaccine industry. GSK and Shanghai Institute are the trailing competitors who acquire 10.04% and 11.60% market share respectively in the global market.

Request a Sample with TOC in a PDF format :

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email :

Back To Top